These findings provethat co-delivery of BTZ and TMZ in Tf-conjugated PLGA NPs is a promisingapproach to treat GBM, overcoming the limitations of current therapeuticstrategies, such as drug resistance and increased side effects. This evidence concerns the gene TF and glioblastoma.